Literature DB >> 31709502

The D-index is not correlated with invasive fungal infection during the early-post engraftment phase among allogeneic hematopoietic stem cell transplant recipients.

Cybele Lara R Abad1, Brian Lahr2, John C O'Horo3, Prakhar Vijayvargiya3, Randall C Walker3, William J Hogan4, Aaron J Tande5.   

Abstract

The D-index assesses neutropenia dynamics. Prolonged neutropenia is a major risk for invasive fungal infection (IFI); we hypothesized that D-index is predictive of IFI risk. We retrospectively reviewed 789 adults who underwent allogeneic hematopoietic transplant (HSCT) from 1/1/2005 to 9/30/2015. Medical records were reviewed from transplant (D0) through Day 100. The D-index was calculated as area over the neutrophil curve until engraftment. 714 patients were included for analysis. Sixteen (2%) developed probable (11) or proven (5) IFI. Median time to IFI was 40 days (range 8-98) after HSCT. Groups with and without IFI did not differ significantly in duration of mild or profound neutropenia. Median D-index of those with IFI was 4293 days neutrophil/µl compared to 3590 days neutrophil/µl for those without IFI (P = 0.17). Patients who were neutropenic on D0 showed higher rates of IFI than those who were not (10/123 [8%] vs 6/591 [1%]; P < 0.001). Only 2% developed IFI, likely due to mold-active antifungal prophylaxis. The D-index was not significantly higher in those with IFI. Duration of profound neutropenia and neutropenia at D0 may be better markers for IFI among HSCT recipients during the first 30 and 100 days after transplant.

Entities:  

Keywords:  D-index; Hematopoietic transplant; Invasive fungal infection

Mesh:

Year:  2019        PMID: 31709502     DOI: 10.1007/s12185-019-02776-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk.

Authors:  E A Engels; C A Ellis; S E Supran; C H Schmid; M Barza; D P Schenkein; Y Koc; K B Miller; J B Wong
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

2.  Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.

Authors:  Shun-Ichi Kimura; Kumi Oshima; Ken Sato; Miki Sato; Kiriko Terasako; Hideki Nakasone; Misato Kikuchi; Shinya Okuda; Shinichi Kako; Rie Yamazaki; Yukie Tanaka; Aki Tanihara; Junji Nishida; Yoshinobu Kanda
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-10       Impact factor: 5.742

3.  D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine.

Authors:  Shun-ichi Kimura; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Ryoko Yamasaki; Masahiro Ashizawa; Tomohito Machishima; Miki Sato; Kiriko Terasako; Hideki Nakasone; Misato Kikuchi; Shinya Okuda; Shinichi Kako; Junya Kanda; Rie Yamazaki; Aki Tanihara; Junji Nishida; Yoshinobu Kanda
Journal:  Hematology       Date:  2013-11-25       Impact factor: 2.269

4.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Authors:  Dimitrios P Kontoyiannis; Kieren A Marr; Benjamin J Park; Barbara D Alexander; Elias J Anaissie; Thomas J Walsh; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa Papanicolaou; Thomas F Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

5.  Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.

Authors:  M Offidani; L Corvatta; A Olivieri; S Rupoli; J Frayfer; A Mele; E Manso; M Montanari; R Centurioni; P Leoni
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

6.  Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation.

Authors:  K Kolbe; D Domkin; H G Derigs; S Bhakdi; C Huber; W E Aulitzky
Journal:  Bone Marrow Transplant       Date:  1997-01       Impact factor: 5.483

7.  Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve.

Authors:  Rodrigo D Portugal; Marcia Garnica; Marcio Nucci
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

8.  Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.

Authors:  S Saavedra; I Jarque; G F Sanz; F Moscardó; C Jiménez; G Martín; G Plumé; A Regadera; J Martínez; J De La Rubia; B Acosta; J Pemán; C Pérez-Bellés; M Gobernado; M A Sanz
Journal:  Clin Microbiol Infect       Date:  2002-11       Impact factor: 8.067

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

Authors:  Kieren A Marr; Rachel A Carter; Michael Boeckh; Paul Martin; Lawrence Corey
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

View more
  2 in total

1.  D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation.

Authors:  Prakhar Vijayvargiya; Cybele Lara Abad; Zerelda Esquer Garrigos; John C O'Horo; Randall C Walker; William J Hogan; Aaron J Tande
Journal:  Transpl Infect Dis       Date:  2021-03-01

2.  c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.

Authors:  Hiroyuki Kubo; Osamu Imataki; Yukiko Hamasaki Kubo; Makiko Uemura
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.